Power and electronic dependency can become a limitation
Transport, emergency and degraded environments can impose charging constraints, limited infrastructure, cold exposure, vibration, logistics burden and reduced maintenance capacity.
MedTech intellectual property · Sophia Antipolis, France
Autonomous Mechanical Infusion Technology
PERFU+3 is a protected mechanical medical technology platform in pre-industrial maturation, designed for emergency, transport and constrained environments where dependence on batteries, electronics or embedded software may become an operational limitation.
100% mechanical
No battery
No electronics
No embedded software
Mechanical by design
Pressure generation and essential operating functions without external electrical power.
100%
mechanical operating principle
3
French patent applications filed
CIR-V40
controlled development baseline
Pre-industrial
maturation & transfer preparation
Why mechanical autonomy
Reducing technical dependency where conditions are demanding
PERFU+3 explores a deliberately simple approach to pressurised infusion: provide controlled mechanical compression of a flexible IV bag without requiring a battery, electronic control unit or embedded software.
Keep the essential function mechanical
The platform is developed around passive mechanical functions for actuation, guidance, pressure application and safety limiting, with the objective of delivering a robust and transferable medical technology architecture.
PERFU+3 technology
A passive mechanical platform for controlled bag pressurisation
PERFU+3 is designed to apply controlled mechanical pressure to flexible infusion bags throughout use, without relying on electrical energy or software-driven control.
01
Mechanical pressure application
Spring energy and guided mechanical transmission are used to apply controlled compression to the infusion bag.
02
Passive safety architecture
Pressure limiting is developed as an independent mechanical function, without dependence on electronic sensing or software logic.
03
Human-factor oriented mechanics
Guiding, handling and anti-error features are integrated mechanically to support straightforward preparation and use.
04
Transfer-oriented engineering
The platform is supported by configuration-controlled technical documentation, engineering definitions, risk work and verification planning for future industrial transfer.
Potential environments of use
Designed for demanding medical contexts
The technological relevance of PERFU+3 is strongest where autonomy, simplicity and reduced dependency on electrical infrastructure are desirable.
01
Emergency & pre-hospital
Rapid-deployment contexts where power infrastructure may not be immediately available.
02
Medical transport
Ground and transport situations where compactness and reduced energy dependency are valuable.
03
Operational health
Potential relevance for tactical and military medical environments requiring robust, battery-free equipment.
04
Disaster response
Degraded or mass-casualty environments in which normal electrical infrastructure cannot be assumed.
05
Remote & austere care
Remote, maritime, mountain or other constrained environments with demanding logistics.
06
Civil protection
Resilience and continuity-of-care scenarios where equipment independence can support operational readiness.
Defence positioning:
military and tactical applications are potential use cases to be evaluated with competent stakeholders.
PERFU+3 is not presented as a military-qualified product.
Development status
A protected technology in pre-industrial maturation
PERFU+3 is not a commercial medical device. AXELYUM MEDTECH is continuing technical maturation, verification preparation and industrial-transfer structuring before partner-led industrialisation and regulatory execution.
Protected platform
Three French patent applications filed. International extension strategy under evaluation.
Controlled baseline
CIR-V40 is maintained as the current controlled development framework as the design matures.
Structured dossier
Design definition, requirements, risk work and verification documentation are maintained under configuration control.
Preparation underway
Industrial transfer documentation and partner-facing materials are being progressively consolidated.
AXELYUM MEDTECH
Develop, protect, mature and transfer mechanical medical technologies
AXELYUM MEDTECH is a French MedTech technology company focused on intellectual property, mechanical medical-device engineering and preparation for industrial transfer.
The company does not position itself as the future series manufacturer. Its model is to create and mature protected technology assets, then engage qualified industrial partners for industrialisation, regulatory execution, manufacturing and market access.
- Legal name
- AXELYUM MEDTECH SASU
- SIREN / SIRET
- 105 779 011 · 105 779 011 00011
- Activity
- 72.19Z — R&D in physical and natural sciences
- Registered office
- Les Aqueducs – Bâtiment 3, 535 Route des Lucioles, 06560 Valbonne, France
- Founder
- Luc Pichotte — Président & Fondateur
- Business model
- IP development · Licensing · Industrial transfer · Co-development
Industrial partnership
Built for qualified industrial dialogue
AXELYUM seeks partners able to assess the technology, contribute to its industrial maturation, execute the regulatory pathway and bring the resulting device to market.
AXELYUM MEDTECH contributes
- Protected mechanical technology and patent portfolio
- Controlled development baseline and technical architecture
- Structured engineering and risk documentation
- Know-how transfer and technical support
- Flexible licensing or co-development framework
The industrial partner contributes
- Design-for-manufacture and industrialisation capability
- Series manufacturing and supplier qualification
- Regulatory strategy and conformity assessment
- Clinical / usability work where required
- Distribution, market access and post-market organisation
Qualified enquiries
Discuss PERFU+3 with AXELYUM MEDTECH
For industrial transfer, licensing, co-development, strategic partnership or institutional discussions. Detailed technical information is shared selectively and, where appropriate, under NDA.
Luc Pichotte · Président & Fondateur
AXELYUM MEDTECH SASU · Sophia Antipolis · France
luc.pichotte@axelyumhealth.com
PERFU+3 is a protected technology platform under development. Please do not send confidential technical information before a suitable NDA is in place.
Open contact form